Skip to main content
Figure 2 | BMC Medicine

Figure 2

From: Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine

Figure 2

Incidence and severity of (a) nausea, (b) constipation, (c) somnolence, (d) sweating, and (e) pruritus. FEN, patients receiving transdermal fentanyl; SRM, patients receiving sustained release oral morphine. 1, incidence at day 1; 2–15, incidences at day 2, 3, etc. Numbers below x-axis show number of patients at each time point.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us